PropertyValue
?:abstract
  • The Centers for Medicare & Medicaid Services (CMS) and other federal agencies are busy churning out regulations and guidance documents in response to the COVID-19 crisis. CMS now requires plans to waive cost sharing for COVID-19-related immunizations, testing, and treatment and suspend utilization review requirements related to drug-supply limits unless these limits are related to patient safety.
?:creator
?:journal
  • Sr_Care_Pharm
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • CMS Responds to COVID-19 Crisis by Revising Regulations
?:type
?:who_covidence_id
  • #32600512
  • #618654
?:year
  • 2020

Metadata

Anon_0  
expand all